These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 12951276

  • 1. Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance.
    Asai M, Kodera T, Ishizeki K, Uebori S, Kashiwaya T, Itoh H, Makino I.
    Diabetes Res Clin Pract; 2003 Aug; 61(2):89-92. PubMed ID: 12951276
    [Abstract] [Full Text] [Related]

  • 2. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report.
    Lahtela JT, Knip M, Paul R, Antonen J, Salmi J.
    Diabetes Care; 1997 Jan; 20(1):71-3. PubMed ID: 9028697
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.
    Fineberg SE, Huang J, Brunelle R, Gulliya KS, Anderson JH.
    Diabetes Care; 2003 Jan; 26(1):89-96. PubMed ID: 12502663
    [Abstract] [Full Text] [Related]

  • 4. Type B insulin resistance in a systemic lupus erythematosus patient.
    Ostwal V, Oak J.
    Int J Rheum Dis; 2009 Jul; 12(2):174-6. PubMed ID: 20374339
    [Abstract] [Full Text] [Related]

  • 5. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI, McTavish D.
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [Abstract] [Full Text] [Related]

  • 6. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.
    Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.
    Diabetes Care; 2002 May; 25(5):883-8. PubMed ID: 11978685
    [Abstract] [Full Text] [Related]

  • 7. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK, Campbell LK, White JR.
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [Abstract] [Full Text] [Related]

  • 8. Lispro analog for treatment of generalized allergy to human insulin.
    Kumar D.
    Diabetes Care; 1997 Sep; 20(9):1357-9. PubMed ID: 9283778
    [Abstract] [Full Text] [Related]

  • 9. Insulin lispro: a review of its use in the management of diabetes mellitus.
    Simpson D, McCormack PL, Keating GM, Lyseng-Williamson KA.
    Drugs; 2007 Sep; 67(3):407-34. PubMed ID: 17335298
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion.
    Castéra V, Dutour-Meyer A, Koeppel M, Petitjean C, Darmon P.
    Diabetes Metab; 2005 Sep; 31(4 Pt 1):391-400. PubMed ID: 16369203
    [Abstract] [Full Text] [Related]

  • 12. Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro.
    Hirsch IB, D'Alessio D, Eng L, Davis C, Lernmark A, Chait A.
    Diabetes Res Clin Pract; 1998 Sep; 41(3):197-202. PubMed ID: 9829349
    [Abstract] [Full Text] [Related]

  • 13. Advantage of insulin lispro in suspected insulin allergy.
    Pánczél P, Hosszúfalusi N, Horváth MM, Horváth A.
    Allergy; 2000 Apr; 55(4):409-10. PubMed ID: 10782533
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus.
    Jehle PM, Fussgänger RD, Seibold A, Lüttke B, Böhm BO.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):498-503. PubMed ID: 8937933
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.
    Koivisto VA, Tuominen JA, Ebeling P.
    Diabetes Care; 1999 Mar; 22(3):459-62. PubMed ID: 10097929
    [Abstract] [Full Text] [Related]

  • 18. Severe autoimmune insulin resistance--a case report.
    Naing A, Ahmed J, Bahk A, Laji K.
    QJM; 2014 Dec; 107(12):1019-21. PubMed ID: 22499892
    [No Abstract] [Full Text] [Related]

  • 19. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.
    Fineberg NS, Fineberg SE, Anderson JH, Birkett MA, Gibson RG, Hufferd S.
    Diabetes; 1996 Dec; 45(12):1750-4. PubMed ID: 8922361
    [Abstract] [Full Text] [Related]

  • 20. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P, Curtillet C, Boullu S, Laugier A, Dutour A, Oliver C.
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.